Conclusion
esophageal squamous cell carcinoma
OESOPHAGEAL SQUAMOUS CELL CARCINOMA
In conclusion, sintilimab maintenance therapy after CCRT can be used as an effective treatment for local relapsed esophageal squamous cell carcinoma with good safety. Further large-scale clinical studies are needed to support the evidence.